The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Vascultis (pulmonary, extrathoracic or systemic)-ANCA status unknown or negative)
Publications
Baldauf MC, Kapauer M, Joerger M, Flatz L, Rodriguez R, Frank S, Felbecker A, Hartmann-Fussenegger S, Hundsberger T
Pembrolizumab-Associated CD8 Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma.
Neurology(R) neuroimmunology & neuroinflammation 2021 07;8; — 2021 07
Coxsackievirus B infection presenting as a hemorrhagic pericardial effusion causing tamponade.
Journal of geriatric cardiology : JGC 2020 Oct 28;17 — 2020 Oct 28 — 642-644